|
1
|
Tsao H, Chin L, Garraway LA and Fisher DE:
Melanoma: From mutations to medicine. Genes Dev. 26:1131–1155.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mateus C and Robert C: Major therapeutic
advances in the treatment of metastatic melanoma. Bull Cancer.
99:619–625. 2012.(In French). PubMed/NCBI
|
|
3
|
Rosenberg E, Horev A and Neulander EZ:
Amelanotic malignant melanoma of the penis. A case report and
literature review. Arch Ital Urol Androl. 84:42–43. 2012.PubMed/NCBI
|
|
4
|
Mikhnin AE, Tarkov SA and Frolova OS:
Cutaneous melanoma in the head and neck region: Current knowledge.
Vopr Onkol. 58:19–25. 2012.(In Russian). PubMed/NCBI
|
|
5
|
Grossmann AH, Grossmann KF and Wallander
ML: Molecular testing in malignant melanoma. Diagn Cytopathol.
40:503–510. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kaufman HL: Vaccines for melanoma and
renal cell carcinoma. Semin Oncol. 39:263–275. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lacy KE, Karagiannis SN and Nestle FO:
Advances in the treatment of melanoma. Clin Med. 12:168–171. 2012.
View Article : Google Scholar
|
|
8
|
Bloomfield JG and Tanay MA: Chemotherapy
in the community: The importance of patient assessment. Br J
Community Nurs. 17:278–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun YX and Liu JC: Chemical constituents
and biological activities of Euphorbia fischeriana Steud.
Chem Biodivers. 8:1205–1214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang YB, Huang R, Wang HB, Jin HZ, Lou LG
and Qin GW: Diterpenoids from the roots of Euphorbia
fischeriana. J Nat Prod. 69:967–970. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smith ME and Bauer-Wu S: Traditional
chinese medicine for cancer-related symptoms. Semin Oncol Nurs.
28:64–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J, Li X, Liu J, Ma L, Li X and Fønnebø
V: Traditional chinese medicine in cancer care: A review of case
reports published in Chinese literature. Forsch Komplementmed.
18:257–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tremante E, Ginebri A, Lo Monaco E,
Frascione P, Di Filippo F, Terrenato I, Benevolo M, Mottolese M,
Pescarmona E and Visca P: Melanoma molecular classes and prognosis
in the postgenomic era. Lancet Oncol. 13:e205–e211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Espinosa E, Berrocal A, López Martín JA,
González Cao M, Cerezuela P, Mayordomo JI and Martín Algarra S:
Grupo Español de Melanoma (GEM): Advances in cutaneous melanoma.
Clin Transl Oncol. 14:325–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sanford M: Ipilimumab: In previously
treated patients with advanced melanoma. Bio Drugs. 26:185–193.
2012.
|
|
17
|
Trinh VA and Hwu WJ: Ipilimumab in the
treatment of melanoma. Expert Opin Biol Ther. 12:773–782. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stratigos AJ, Forsea AM, van der Leest RJ,
de Vries E, Nagore E, Bulliard JL, Trakatelli M, Paoli J, Peris K,
Hercogova J, et al: Euromelanoma: A dermatology-led European
campaign against nonmelanoma skin cancer and cutaneous melanoma.
Past, present and future. Br J Dermatol. 167:99–104. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smalley KS and McArthur GA: The current
state of targeted therapy in melanoma: This time it's personal.
Semin Oncol. 39:204–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mathew R and Messina JL: Recent advances
in pathologic evaluation and reporting of melanoma. Semin Oncol.
39:184–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Silva E: Adjunct primer for the use of
national comprehensive cancer network guidelines for the surgical
management of cutaneous malignant melanoma patients. World J Surg
Oncol. 6:542012. View Article : Google Scholar
|
|
22
|
Flaherty KT, Hodi FS and Fisher DE: From
genes to drugs: Targeted strategies for melanoma. Nat Rev Cancer.
12:349–361. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aguissa-Touré AH and Li G: Genetic
alterations of PTEN in human melanoma. Cell Mol Life Sci.
69:1475–1491. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu H, Goel V and Haluska FG: PTEN
signaling pathways in melanoma. Oncogene. 22:3113–3122. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Madhunapantula SV and Robertson GP: The
PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.
Pigment Cell Melanoma Res. 22:400–419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meier F, Schittek B, Busch S, Garbe C,
Smalley K, Satyamoorthy K, Li G and Herlyn M: The RAS/RAF/MEK/ERK
and PI3K/AKT signaling pathways present molecular targets for the
effective treatment of advanced melanoma. Front Biosci.
10:2986–3001. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davies MA: The role of the PI3K-AKT
pathway in melanoma. Cancer J. 18:142–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Willems L, Tamburini J, Chapuis N, Lacombe
C, Mayeux P and Bouscary D: PI3K and mTOR signaling pathways in
cancer: New data on targeted therapies. Curr Oncol Rep. 14:129–138.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bartholomeusz C and Gonzalez-Angulo AM:
Targeting the PI3K signaling pathway in cancer therapy. Expert Opin
Ther Targets. 16:121–130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Y, Wang BC and Xiao Y: PI3K: A
potential therapeutic target for cancer. J Cell Physiol.
227:2818–2821. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu B and Zhou X: The study of PI3K/AKT
pathway in lung cancer metastasis and drug resistance. Zhongguo Fei
Ai Za Zhi. 14:689–694. 2011.(In Chinese). PubMed/NCBI
|
|
32
|
Lin H, Liu J and Zhang Y: Developments in
cancer prevention and treatment using traditional chinese medicine.
Front Med. 5:127–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang JY, Xu L, Zhang RX and Lao L:
Traditional chinese medicine for cancer pain. Zhong Xi Yi Jie He
Xue Bao. 9:129–134. 2011.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou TX, Bao GH, Ma QG, Che CT, Lv Y, Wang
C and Zheng QT: Langduin C, a novel dimeric diterpenoid from the
roots of Euphorbia fischeriana. Tetrahedron Lett.
44:135–137. 2003. View Article : Google Scholar
|
|
35
|
Wang JH, Zhang K, Niu HY, Shu LH, Yue DM,
Li D and He P: Jolkinolide B from Euphorbia fischeriana
Steud induces in human leukemic cells apoptosis via JAK2/STAT3
pathways. Int J Clin Pharmacol Ther. 51:170–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pon D, Wang Z, Le KN and Chow MS:
Harnessing traditional Chinese medicine to improve cancer therapy:
Issues for future development. Ther Deliv. 1:335–344. 2010.
View Article : Google Scholar : PubMed/NCBI
|
